In this article, our experts detail the validation strategy of the Growth Direct System for analysis of environmental samples in a controlled manufacturing environment. The validation strategy used follows the process defined in the PDA TR33 report and in compliance with the pharmacopeia USP <1223> and PhEur 5.1.6.
Fill out the form to get your copy today.